A detailed history of Geode Capital Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,131,629 shares of CDXC stock, worth $6.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,131,629
Previous 561,059 101.7%
Holding current value
$6.63 Million
Previous $1.95 Million 58.25%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.44 - $4.32 $1.39 Million - $2.46 Million
570,570 Added 101.7%
1,131,629 $3.09 Million
Q1 2024

May 13, 2024

BUY
$1.36 - $3.84 $77,677 - $219,325
57,116 Added 11.33%
561,059 $1.95 Million
Q3 2023

Nov 13, 2023

SELL
$1.36 - $1.77 $27,820 - $36,207
-20,456 Reduced 3.9%
503,943 $735,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $1.79 $43,277 - $59,134
-33,036 Reduced 5.93%
524,399 $823,000
Q1 2023

May 15, 2023

SELL
$1.48 - $2.19 $2,092 - $3,096
-1,414 Reduced 0.25%
557,435 $852,000
Q4 2022

Feb 13, 2023

BUY
$1.25 - $1.94 $6,905 - $10,716
5,524 Added 1.0%
558,849 $938,000
Q3 2022

Nov 14, 2022

BUY
$1.19 - $2.06 $5,459 - $9,451
4,588 Added 0.84%
553,325 $680,000
Q2 2022

Aug 12, 2022

SELL
$1.59 - $2.7 $596,768 - $1.01 Million
-375,326 Reduced 40.62%
548,737 $916,000
Q1 2022

May 13, 2022

BUY
$2.02 - $3.92 $86,445 - $167,756
42,795 Added 4.86%
924,063 $2.27 Million
Q4 2021

Feb 11, 2022

BUY
$3.74 - $6.7 $63,781 - $114,261
17,054 Added 1.97%
881,268 $3.3 Million
Q3 2021

Nov 12, 2021

BUY
$6.05 - $10.41 $263,066 - $452,647
43,482 Added 5.3%
864,214 $5.42 Million
Q2 2021

Aug 13, 2021

BUY
$6.66 - $10.92 $566,066 - $928,145
84,995 Added 11.55%
820,732 $8.09 Million
Q1 2021

May 12, 2021

BUY
$4.59 - $18.74 $364,042 - $1.49 Million
79,312 Added 12.08%
735,737 $6.87 Million
Q4 2020

Feb 12, 2021

BUY
$3.93 - $5.5 $104,494 - $146,239
26,589 Added 4.22%
656,425 $3.15 Million
Q3 2020

Nov 13, 2020

BUY
$4.01 - $5.56 $67,584 - $93,708
16,854 Added 2.75%
629,836 $2.53 Million
Q2 2020

Aug 13, 2020

BUY
$3.0 - $5.52 $76,050 - $139,932
25,350 Added 4.31%
612,982 $2.81 Million
Q1 2020

May 14, 2020

BUY
$2.54 - $4.75 $225,295 - $421,320
88,699 Added 17.78%
587,632 $1.92 Million
Q4 2019

Feb 13, 2020

BUY
$2.83 - $4.61 $186,106 - $303,162
65,762 Added 15.18%
498,933 $2.15 Million
Q3 2019

Nov 12, 2019

BUY
$3.83 - $4.72 $58,277 - $71,819
15,216 Added 3.64%
433,171 $1.7 Million
Q2 2019

Aug 14, 2019

BUY
$3.71 - $4.83 $142,167 - $185,085
38,320 Added 10.09%
417,955 $1.94 Million
Q1 2019

May 14, 2019

BUY
$3.2 - $4.19 $105,318 - $137,901
32,912 Added 9.49%
379,635 $1.59 Million
Q4 2018

Feb 13, 2019

BUY
$2.8 - $4.22 $48,610 - $73,263
17,361 Added 5.27%
346,723 $1.19 Million
Q3 2018

Nov 13, 2018

BUY
$3.5 - $4.91 $119,430 - $167,543
34,123 Added 11.56%
329,362 $1.41 Million
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $385,762 - $530,722
119,802 Added 68.29%
295,239 $1.1 Million
Q3 2017

Nov 14, 2017

BUY
$2.91 - $4.71 $25,427 - $41,155
8,738 Added 5.24%
175,437 $754,000
Q2 2017

Aug 14, 2017

BUY
N/A
166,699
166,699 $636,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $401M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.